| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Akanda Corp. Common Shares$16.18
+1.11 (+7.37%)
Market Cap
1.26 M
EPS
-
P/E Ratio
-
Value Trade
522.07 K
%
Week
%
1 Month
%
3 Month
%
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
12.35 K
Monthly Burn
12.35 K
Runway
12,345 mo
Overview
Volume
59.10 K
52 Week Range
0.51 - 46.45
% held by Insiders
0 %
% held by Institutions
1.89 %
Enterprise Value
-
Total Shares
2.41 M
Short %
3.47 %
Float Shares
2.18 M
Company Description
locked
Upcoming Catalyst
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in AKAN
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
Akanda Corp. Common Shares (AKAN) Analyst Ratings & Price Targets
Symbol
Firm
Rating
Action
Price Target
Upside
date
AKAN
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
AKAN
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
AKAN
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
AKAN Stock Forecast & Analyst Consensus
BUY
Analyst Ratings
Buy65.0%
Hold25.0%
Sell10.0%
Price Target Trend
Average$24.00
Low$18.00
High$32.00
AKAN Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-AKAN
Jun 18, 2026Akanda Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement TORONTO, ON
Akanda Corp. received a notification from Nasdaq indicating non-compliance with the minimum stockholders' equity requirement, as the company's equity was reported at -$11,990,437. Following the guidelines, the company must submit a plan to regain compliance within 45 days. If accepted, Nasdaq may allow an additional 180 days for Akanda to rectify its situation. The notification does not immediately affect the listing status of its shares on Nasdaq.
Read more →-AKAN
Jun 12, 2026Akanda Corp. Regains Compliance with Nasdaq Periodic Filing Requirement Filing of Annual Report on Form 20-F for Fiscal 2025 Restores Compliance with Nasdaq Listing Rule 5250(c)(1) TORONTO, ON
Akanda Corp. has regained compliance with Nasdaq’s periodic filing requirement by submitting its Annual Report on Form 20-F for fiscal 2025. The Nasdaq informed the company that it was previously not in compliance due to a missed filing, but this issue has now been resolved. Akanda aims to provide accessible cannabis products and expand its operations in Mexico with fiber optic networks.
Read more →-AKAN
May 22, 2026Akanda Corp. Announces Receipt of NASDAQ Noncompliance Letter TORONTO, ON
Akanda Corp. has announced that it is not in compliance with Nasdaq listing rules due to the failure to file its Annual Report on Form 20-F for the fiscal year ending December 31, 2025. The company is required to submit a plan by July 19, 2026, detailing how it intends to regain compliance, with no assurance that this plan will be accepted. If management fails to restore compliance in the stipulated timeline, the company could face delisting from Nasdaq.
Read more →-AKAN
May 13, 2026Notice of ADJOURNED Special Meeting of Shareholders NOTICE IS HEREBY GIVEN THAT a special meeting of the shareholders (the Meeting ) of Akanda Corp. (the Corporation ) originally scheduled for
Akanda Corp. has announced that its special meeting of shareholders, originally scheduled for March 31, 2026, has been adjourned to May 25, 2026. The meetings are important for fulfilling Nasdaq exchange requirements and to introduce new business. Shareholders can attend in person or via Zoom, though remote participants will not have voting rights. Proxies from previous meetings will be honored, and the corporation has extended the proxy submission deadline.
Read more →-AKAN
Apr 29, 2026Akanda Adjourns Shareholder Meeting Toronto, Ontario
Akanda Corp. announced the adjournment of its Special Meeting of Shareholders due to insufficient quorum. The meeting will reconvene on May 25, 2026, to allow more time for proxy solicitation. Shareholders who have voted do not need to act again, as their previous votes will still count. The company emphasizes the importance of shareholder participation for the reconvened meeting.
Read more →-AKAN
Apr 9, 2026Akanda Corp. Announces Reverse Stock Split TORONTO, ON
Akanda Corp. announced a 1-for-4.5 reverse stock split, which is set to take effect on April 13, 2026. This decision was approved by shareholders and the Board of Directors in previous meetings. The reverse split aims to reduce the number of outstanding shares from approximately 2.4 million to about 534.4 thousand. All shareholders will be affected uniformly, although adjustments will occur for any fractional shares. The company remains focused on its cannabis operations and expanding its fiber optic network in Latin America.
Read more →-AKAN
Mar 31, 2026AKANDA CORP. NOTICE OF SPECIAL MEETING TO BE HELD ON MARCH 31, 2026 AND MANAGEMENT INFORMATION CIRCULAR FEBRUARY 26, 2026 AKANDA CORP. NOTICE OF SPECIAL MEETING OF SHAREHOLDERS (the "Notice") NOTICE IS HEREBY GIVEN that
Akanda Corp. has announced a special meeting for shareholders scheduled for March 31, 2026, to be held in Toronto and available via Zoom. Shareholders must attend in person or provide a proxy to vote at the meeting. The company encourages shareholders to read the accompanying information circular for important details regarding the meeting agenda. The record date for determining eligible shareholders is set for February 25, 2026.
Read more →-AKAN
Mar 26, 2026Ontario Ministry of Government and Consumer Services Articles of Amendment Business Corporations Act Instructions For questions or more information to complete this form, please refer to the instruction page. Fields mark
The article provides detailed instructions from the Ontario Ministry of Government and Consumer Services regarding the Articles of Amendment under the Business Corporations Act. It outlines mandatory fields and necessary information for corporate filings, including details about the corporation's name, contact information, director information, and changes to shares and provisions. Specific amendments, such as the consolidation of shares, are also mentioned, emphasizing the legal requirements for ensuring all filings comply with the Act. A confirmation of authorization by the director and caution regarding penalties for misinformation are also included.
Read more →-AKAN
Mar 26, 2026Akanda Corp. Driving Recurring Revenue Growth: $2 Million Cash Flow Secured Through Fiber Acquisition Toronto, Ontario--(Newsfile Corp.
Akanda Corp. has announced a significant expansion of its dark fiber network, acquiring approximately 200 kilometers of infrastructure, which is expected to generate $2 million in contracted cash flow over ten years. This acquisition furthers the company's strategy to establish a high-margin, cash-generating digital infrastructure platform in a rapidly growing market in Mexico. The added network will increase total coverage to 900 kilometers, positioning Akanda to capture further revenue by leasing additional strands to various enterprises. The company's management is optimistic about this expansion, citing its potential to accelerate growth and enhance shareholder value.
Read more →-AKAN
Feb 27, 2026First Towers & Fiber Corp. Owns The Largest Dark Fiber Network In Central Mexico Toronto, Ontario--(Newsfile Corp.
Akanda Corp. and its subsidiary, First Towers & Fiber Corp., have announced plans to expand their dark fiber leasing operations in Central Mexico. The approximately 700-kilometre dark fiber network, the largest in the region, is already leased to Telefónica and Marcatel, with ample capacity for future customers. The scalable design of the network supports increased leasing opportunities, which the company expects to leverage to boost recurring revenue. With an established regional presence, FTF aims to meet the rising demand for high-capacity fiber infrastructure.
Read more →-AKAN
Jan 23, 2026Akanda Announces Closing of $7.0 Million Convertible Note Offering Toronto, Ontario
Akanda Corp. announced the successful closing of a $7.0 million convertible note offering as part of a private placement transaction. The proceeds from this offering will be primarily used for marketing, working capital, and debt obligations. Despite this positive development, the company has stated that the notes are not registered under the Securities Act, which may restrict their sale in certain jurisdictions. Additionally, Akanda faces several challenges, including competition and the need to effectively manage its growth and debt.
Read more →-AKAN
Jan 20, 2026Akanda Announces $7.0 Million Convertible Note Offering Toronto, Ontario
Akanda Corp. announced a $7.0 million convertible note offering to institutional investors, expected to close on January 21, 2026. The funds raised will be allocated for marketing, working capital, and debt repayment. This move reflects the company's strategic financial planning and aims to bolster its operational capabilities.
Read more →-AKAN
Dec 18, 2025Akanda Corp. Welcomes Momentum Towards Cannabis Reform in the United States Toronto, Ontario
Akanda Corp. expresses support for the U.S. government's potential reclassification of cannabis from Schedule I to Schedule III, highlighting the importance of modernizing cannabis policies. The interim CEO emphasized the benefits of a science-led, public-health approach, which could enhance medical research and consumer safety while addressing illicit supply chains. The company advocates for reforms focused on measurable outcomes similar to Canada's comprehensive cannabis legislation. Akanda aims to provide high-quality cannabis products and improve wellness through its business operations.
Read more →-AKAN
Nov 13, 2025Akanda Researching Security Requirements For Full Cultivation License Toronto, Ontario--(Newsfile Corp.
Akanda Corp. is actively researching security requirements for obtaining a full cultivation license in Ontario. The company has extended its option on a British Columbia asset for two more years while intending to develop THC and CBD products. To prepare for future licensing inspections, Akanda plans to implement Health Canada-compliant security measures at its site. The company aims to leverage its strategic vision in the growing Canadian cannabis market, projected to expand significantly by 2030.
Read more →-AKAN
Oct 30, 2025Notice of ADJOURNED Special Meeting of Shareholders NOTICE IS HEREBY GIVEN THAT a special meeting of the shareholders (the " Meeting ") of Akanda Corp. (the " Corporation ") originally scheduled for
Akanda Corp. has adjourned its special meeting of shareholders originally scheduled for October 30, 2025, to November 28, 2025. This adjournment allows the company to meet Nasdaq exchange requirements and address new business. Shareholders can attend in person or watch the meeting via Zoom, although remote participants will have limited engagement rights. The meeting will cover original business as well as new proposals, and management urges a vote in favor of all resolutions presented.
Read more →-AKAN
Oct 20, 2025Akanda Corp. Increasing Its Cannabis Investment Toronto, Ontario--(Newsfile Corp.
Akanda Corp. is increasing its cannabis investment by extending its option on its British Columbia asset for two more years. The company is pursuing a full cultivation license to develop THC and CBD products at its facility on Gabriola Island, known for favorable growth conditions. This strategic move illustrates Akanda's commitment to solidifying its role in the global cannabis industry while focusing on high-quality cannabis production.
Read more →-AKAN
Oct 16, 2025Akanda To Accelerate Recurring Revenue with Expansion Of Up To 20 New Cellular Towers Toronto, Ontario--(Newsfile Corp.
Akanda Corp. is undertaking a significant expansion initiative through its subsidiary First Towers & Fiber Corp., planning to construct or acquire up to 20 new cellular towers by the end of 2025. This strategic investment aims to enhance network capacity, strengthen coverage, and drive recurring revenue. Currently, FTF operates 30 revenue-generating towers and a 700-kilometer dark fiber network, and this expansion is set to solidify its position in Mexico's telecommunications sector. The initiative is expected to increase cash flow and align with the growing demand for mobile data and connectivity solutions in the region.
Read more →-AKAN
Oct 10, 2025Akanda Corp. Addresses Impacts of Postal Strike on Receiving Materials for its Upcoming Special Meeting Toronto, Ontario
Akanda Corp. announced that due to an ongoing postal strike in Canada, it is unable to mail shareholder proxy materials for its upcoming special meeting scheduled for October 30, 2025. To address this issue, the company has put in place alternative delivery procedures allowing shareholders to access meeting materials online or request printed copies through email or courier. The company assures that these measures will guarantee timely access to important information despite the disruptions caused by the postal strike.
Read more →-AKAN
Oct 9, 2025AKANDA CORP. NOTICE OF SPECIAL MEETING TO BE HELD ON OCTOBER 30, 2025 AND MANAGEMENT INFORMATION CIRCULAR SEPTEMBER 29, 2025 AKANDA CORP. NOTICE OF SPECIAL MEETING OF SHAREHOLDERS (the "Notice") NOTICE IS HEREBY GIVEN th
Akanda Corp. has announced a special meeting of shareholders to be held on October 30, 2025, at their Toronto offices, with a virtual option via Zoom. The meeting will focus on several key matters as outlined in the associated management information circular. Shareholders are encouraged to review the circular in detail prior to the meeting to prepare for discussions and voting.
Read more →-AKAN
Oct 1, 2025Akanda Corp. Unaudited Condensed Interim Consolidated Statements of Financial Position (Expressed in United States Dollars) June 30, December 31, As at Note 2025 2024 ASSETS Current Cash $ 2,523,719 $ 3,838,650 Cash held
Akanda Corp. has released its unaudited condensed interim consolidated financial statements for the period ending June 30, 2025. The organization reported a net loss of $815,001, reflecting a significant decrease from previous losses. Assets decreased considerably from $7.91 million at the end of 2024 to $6.22 million by mid-2025, emphasizing current financial challenges. Notably, current liabilities totaled approximately $2.84 million, which contributes to ongoing concerns about the company's liquidity and profitability.
Read more →-AKAN
Sep 30, 2025Akanda Among the Leaders of Deployment in Mexico's Largest Telecommunication Infrastructure Project Toronto, Ontario--(Newsfile Corp.
Akanda Corp. has highlighted its subsidiary, First Towers & Fiber Corp. (FTF), as a pivotal player in Mexico's largest telecommunications infrastructure project, focusing on increasing data connectivity. FTF has successfully deployed 30 cellular towers and operates over 700 kilometers of dark fiber network, primarily leased to Telefonica. The initiative is expected to enhance communications and drive economic growth in the region. However, the company faces risks including stockholder approval for planned share issuance and potential challenges from litigation and market competition.
Read more →-AKAN
Sep 12, 2025Akanda Announces $12.0 Million Convertible Note Offering Toronto, Ontario
Akanda Corp. has successfully executed a securities purchase agreement to raise up to $12.0 million through 12-month convertible promissory notes. The capital will be utilized for various purposes, including marketing, site development, working capital, and debt repayment. This offering has not been registered under the Securities Act, which may limit its immediate accessibility. The company also highlights several forward-looking risks that could potentially impact its performance and growth prospects.
Read more →-AKAN
Aug 22, 2025AKANDA CORP. ANNOUNCES CLOSING OF SHARE EXCHANGE WITH FIRST TOWERS AND FIBER CORP. First Towers develops, constructs and owns telecommunications infrastructure in Mexico Akanda Reaffirms its Continued Focus on the Growth
Akanda Corp has announced the completion of its share exchange with First Towers, making it a wholly-owned subsidiary. As part of this transaction, Akanda will issue convertible shares and has taken on First Towers' existing liabilities. The company also reaffirmed its focus on developing its pre-revenue cannabis farming property in British Columbia. However, the issuance of the new shares is contingent on shareholder approval, adding uncertainty to the deal. Akanda emphasizes its commitment to expand its operations in the cannabis sector.
Read more →-AKAN
Aug 8, 2025AKANDA CORP. NOTICE OF SPECIAL MEETING TO BE HELD ON AUGUST 29, 2025 AND MANAGEMENT INFORMATION CIRCULAR JULY 29, 2025 - i - AKANDA CORP. NOTICE OF SPECIAL MEETING OF SHAREHOLDERS (the "Notice") NOTICE IS HEREBY GIVEN th
Akanda Corp. has announced a special meeting of shareholders scheduled for August 29, 2025. The meeting will be held in person at their Toronto offices and will also be available via Zoom for observation only. Shareholders must attend in person or submit a proxy to vote. The record date for determining eligible shareholders is July 28, 2025, and additional details can be found in the accompanying management information circular.
Read more →-AKAN
Apr 16, 2025AKANDA CORP. NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING TO BE HELD ON APRIL 30, 2025 AND MANAGEMENT INFORMATION CIRCULAR APRIL 11, 2025 - i - AKANDA CORP. NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS (t
Akanda Corp. has announced its Annual General and Special Meeting scheduled for April 30, 2025, to be held in Toronto and simulcast via Zoom. Shareholders will need to attend in person or submit a proxy to vote, as virtual participants cannot engage in the voting process. The record date for determining eligible shareholders is set for April 8, 2025. An accompanying management information circular provides details on the agenda and voting procedures.
Read more →-AKAN
Mar 5, 2025SHARE EXCHANGE AGREEMENT THIS SHARE EXCHANGE AGREEMENT is made effective as of
Akanda Corp. has entered into a Share Exchange Agreement with First Towers & Fibers Corp., effective March 5, 2025. According to the agreement, the acquisition involves the exchange of Company Shares for Cash Payment or Payment Shares. The process will be conducted according to the specified terms and conditions, including relevant disclosures and financial statements pertaining to the transaction. The Exchange Ratio is established at one Payment Share for every 2.5 Company Shares.
Read more →-AKAN
Nov 12, 2024Akanda Corp. Announces Reverse Stock Split LONDON, UK
Akanda Corp. announced a 1-for-2 reverse stock split set to take effect on November 14, 2024, as part of ongoing efforts to improve its capital structure. This decision follows prior shareholder and Board approvals for share consolidations, including previous 1-for-40 and potential future ratios. The reverse stock split aims to reduce the number of outstanding shares, facilitating compliance with Nasdaq standards. The company continues to navigate challenges related to its operational history and revenue generation.
Read more →-AKAN
Oct 30, 2024Akanda Corp. Unaudited Condensed Interim Consolidated Statements of Financial Position (Expressed in United States Dollars) As at June 30, December 31, Note 2024 2023 ASSETS Current Cash $ 6,013,262 $ 82,816 Cash held in
Akanda Corp. reported unaudited financial results for the six months ending June 30, 2024, showing a loss of $2.68 million compared to a loss of $5.88 million in the previous year. The company’s total assets increased to approximately $9.97 million, primarily driven by a rise in cash assets. However, the liabilities remain high, resulting in an accumulated deficit of over $56 million. Despite a notable increase in sales, the operating expenses continue to outpace revenue, indicating financial strain ahead.
Read more →-AKAN
Oct 4, 2024Akanda Corp. Announces Closing of Underwritten Public Offering London
Akanda Corp. recently completed an underwritten public offering, selling a total of 258,940 common shares and 1,241,060 pre-funded warrants. The offering generated gross proceeds of $1.5 million, which the company intends to utilize for capital expenditures, enhancing operational capacity, and other general corporate purposes. The issuance was executed under the effective registration statement filed with the SEC and closed on October 3, 2024.
Read more →-AKAN
Oct 2, 2024Akanda Corp. Announces Pricing of Underwritten Public Offering London
Akanda Corp. has announced the pricing of an underwritten public offering, agreeing to sell 1,500,000 common shares at $1.00 per share. The offering is projected to generate approximately $1,500,000 in gross proceeds, which will be allocated toward capital expenditures, operating capacity, and potential acquisitions. The transaction is expected to close on or about October 3, 2024, pending customary closing conditions. The company emphasizes its commitment to safety and accessibility in the cannabis industry.
Read more →-AKAN
Sep 16, 2024Akanda Corp. Secures Hemp Cultivation License in Canada, Building on Previous Development Agreement London, United Kingdom
Akanda Corp. has announced the successful acquisition of a hemp cultivation license in Canada, building on its prior agreement with 1107385 B.C. LTD. This development is part of the company’s broader strategy to strengthen its presence in the Canadian cannabis market. The license obliges Akanda to fulfill a milestone payment of $750,000 in the coming week. The company aims to establish itself as a leader in the global cannabis sector, focusing on high-quality medical cannabis and sustainable practices.
Read more →-AKAN
Jun 14, 2024Akanda Corporation announces completion of F-3 shelf registration statement London, United Kingdom--(Newsfile Corp.
Akanda Corporation has announced the successful completion of its F-3 shelf registration, raising nearly $5 million through public offerings since its declaration effective on January 29, 2024. The company maximized the capacity of this registration statement and will not issue further funds under it. Future fundraising efforts will require a newly filed registration statement. Akanda continues to strengthen its position in the medical cannabis industry with plans to develop facilities in Canada and partnerships in the United Kingdom.
Read more →-AKAN
Jun 12, 2024Akanda Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement London, UK
Akanda Corp. has announced its regaining of compliance with Nasdaq's Minimum Bid Price Requirement, as it received a Compliance Notice confirming the closure of a previous non-compliance issue. The company maintained a closing bid price of $1 or greater for 10 consecutive business days, meeting the necessary criteria. Akanda continues to operate as an international medical cannabis company, focusing on providing high-quality products through various initiatives, including partnerships and acquisitions in the UK and Canada.
Read more →-AKAN
May 21, 2024AKANDA ANNOUNCES STOCK CONSOLIDATION London, UK
Akanda Corp. announced a 1-for-40 reverse stock split effective May 23, 2024, to improve its stock performance. Following this split, shares will trade on a split-adjusted basis on the Nasdaq under the symbol 'AKAN'. The decision was approved by the company's board and shareholders, aiming to support Akanda's ongoing initiatives in the medical cannabis sector. The reverse stock split will not alter shareholders' overall ownership percentage, barring adjustments for fractional shares.
Read more →-AKAN
May 17, 2024Akanda Announces Closing of Registered Direct Offering London
Akanda Corp. has successfully closed its registered direct offering, raising about $2.5 million through the sale of common shares and pre-funded warrants. The company plans to use the proceeds for various corporate purposes, including capital expenditures and the repayment of existing debts. This offering follows the SEC's approval under an effective shelf registration statement. Akanda, which operates in the medical cannabis sector, seeks to enhance access to quality cannabis products.
Read more →-AKAN
May 17, 2024Akanda Corp. Announces Registered Direct Offering London
Akanda Corp. has announced a registered direct offering under a securities purchase agreement with an accredited investor. The deal involves the sale of 2,491,381 common shares at $0.1031 each and 21,756,922 pre-funded warrants at $0.103 per share. Expected gross proceeds are around $2.5 million, which will support general working capital needs. The offering is anticipated to finalize on May 17, 2024, pending customary closing conditions.
Read more →-AKAN
May 16, 2024AKANDA CORP. RECEIVES NOTICE OF NON-COMPLIANCE FROM NASDAQ London, UK
Akanda Corp.received a deficiency notification from Nasdaq due to non-compliance with the minimum stockholders' equity requirement. As reported, its stockholders' equity was negative at ($3,828,892), which does not meet Nasdaq's standard. The company has 45 days to submit a plan to regain compliance and is actively working on resolving the issue. Importantly, there is currently no impact on Akanda's Nasdaq listing, and its shares continue to trade as normal.
Read more →-AKAN
May 13, 2024AKANDA CORP ANNOUNCES SETTLEMENT AGREEMENT WITH FORMER CEO TEJINDER VIRK London, UK
Akanda Corp has reached a settlement agreement with former CEO Tejinder Virk, effectively resolving disputes that followed his resignation in February 2023. This agreement will allow all parties to concentrate on their future endeavors without the burden of past disagreements. CEO Katharyn Field highlighted that this settlement is in the best interest of everyone involved, facilitating a focused approach on the company's strategic objectives. The resolution ensures that Akanda can move forward effectively in the medical cannabis and wellness market.
Read more →-AKAN
May 10, 2024Akanda Corp. Announces Plans to Be Among International First Movers Pending Completion of Landmark Change in US Drug Policy London, United Kingdom--(Newsfile Corp.
Akanda Corp. announced its intentions to capitalize on the potential rescheduling of cannabis to a Schedule III substance under the Controlled Substances Act. The company believes this change could enhance capital market access and allow for consolidation within the US cannabis sector. This shift is anticipated to lower prices for consumers and increase legal consumption capabilities. However, the proposed rule changes are still awaiting approval from the White House Office of Management and Budget, with public comments required before finalization.
Read more →-AKAN
Apr 25, 2024AKANDA APPOINTS COOPER TO THE BOARD OF DIRECTORS London, UK
Akanda Corp. has appointed Christopher Cooper to its board of directors following the resignation of Harvinder Singh. Cooper brings over 20 years of experience in corporate development and finance, having served on the boards of various public and private companies. His notable recent roles include director positions at Alpha Lithium Corporation and Counterpath Corporation. The company continues to aim for growth and enhanced service delivery in the medical cannabis and wellness sectors.
Read more →-AKAN
Apr 15, 2024Akanda Announces No Equity Financing Until Further Notice London, UK
Akanda Corp. has announced a pause on any potential equity financing for a period of thirty days as the Board evaluates strategic investment opportunities. This decision follows the completion of public offerings totaling nearly $6 million and the sale of its subsidiary, RPK BioPharma, which helped reduce debt and improve cash flow. Interim CEO Katie Field emphasized a cautious approach to future investments, prioritizing opportunities that do not increase the company's burn rate.
Read more →-AKAN
Apr 12, 2024Akanda Looks to Commercialize and Capitalize on Germany's Legalization of Cannabis, Opening Path to $3BN Market London, UK
Akanda Corp. is looking to capitalize on Germany's recent legalization of cannabis for personal use, which is anticipated to create a significant market opportunity valued at approximately $3 billion. With an established presence in the medical cannabis sector, Akanda plans to explore strategic investments and acquisitions in Germany, focusing on cultivation and retail, drawing on their management's significant experience. The company is optimistic about the increase in consumer demand and plans to closely monitor regulatory developments to advance its business objectives in this burgeoning market.
Read more →-AKAN
Apr 11, 2024Akanda Corp. Announces Closing of the Sale of RPK London
Akanda Corp. has successfully closed the sale of its indirect wholly-owned subsidiary, RPK, to Somai Pharmaceuticals for $2 million and the assumption of up to 4 million Euros in debt. This transaction is expected to enhance Akanda's financial position, allowing for more strategic developments such as the Gabriola Green Project in British Columbia. The company aims to strengthen its presence in the global cannabis market, with Canmart as a key component of its strategy. Interim CEO Katie Field expressed optimism about the company's anticipated growth following this sale.
Read more →-AKAN
Mar 28, 2024Akanda Corp. Announces Strategic Plan to Evaluate and Enter Bitcoin, Blockchain, AI Segments of the Cannabis Market London
Akanda Corp. has unveiled its strategic plan to investigate opportunities in Bitcoin, Blockchain, and AI within the cannabis industry. This initiative aims to address banking challenges faced by cannabis operators and enhance quality control in the supply chain. The company is leveraging Blockchain for secure tracking of Certificates of Analysis and exploring AI applications to optimize cannabis cultivation. With a stronger financial position following a recent public offering, Akanda is set to expand its presence in both the UK and North American markets.
Read more →-AKAN
Mar 11, 2024AKANDA CORP. NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING TO BE HELD ON MARCH 22, 2024 AND MANAGEMENT INFORMATION CIRCULAR MARCH 12, 2024 - i - AKANDA CORP. NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS (t
Akanda Corp. has announced its Annual General and Special Meeting to be held on March 22, 2024, at their Vancouver offices and via Zoom. Shareholders will be voting on critical matters, including a significant transaction concerning the sale of a property. Attendance in person or via a proxy is required for voting, while those attending via Zoom will not be able to interact or vote. A reminder to review the Management Information Circular prior to the meeting is emphasized, as it contains important information about the matters to be addressed.
Read more →-AKAN
Feb 29, 2024Akanda Corp. Signs Share Purchase and Escrow Agreements for the Sale of Portuguese Assets to Somai Pharmaceuticals London
Akanda Corp. has signed a Share Purchase Agreement with Somai Pharmaceuticals for the sale of its Portuguese subsidiary, RPK BioPharma. The deal, valued at $2 million, includes a $500,000 deposit placed in escrow. This transaction marks an important step in Akanda's strategy to improve its financial stability and advance its presence in the global cannabis market. Additionally, Akanda emphasizes its commitment to providing high-quality cannabis products through its UK subsidiary, Canmart, and ongoing projects in Canada.
Read more →-AKAN
Feb 20, 2024Akanda Corp. Provides Further Update on Annual Meeting of its Shareholders London
Akanda Corp. has announced that it received an order from the Ontario Superior Court of Justice allowing it to hold its annual meeting of shareholders by March 23, 2024, an extension from the previous deadline of February 22, 2024. This delay allows the company to better prepare for the meeting amidst its ongoing activities in the medical cannabis sector. Akanda continues to emphasize its commitment to improving access to quality products through its various partnerships across Europe and California.
Read more →-AKAN
Feb 20, 2024Akanda Corp. Provides Update on Annual Meeting of its Shareholders London
Akanda Corp. announced that it is applying to the Ontario Superior Court for an extension to hold its annual shareholders' meeting, moving the date from February 22, 2024, to March 23, 2024. This decision is linked to ongoing negotiations for a potential transaction involving the sale of its subsidiary, RPK Biopharma. Akanda aims to combine this transaction approval with other matters to avoid additional costs associated with holding two separate meetings. The outcome hinges on the court's decision, which is expected soon, although there are no guarantees regarding the transaction's success or court approval.
Read more →-AKAN
Feb 13, 2024Akanda Corp. Discusses Positive Trends in UK Cannabis Market London
Akanda Corp. highlighted the significant growth in the UK cannabis market, showcasing that medical cannabis imports have tripled in volume since 2022. With over 29 million adults potentially eligible for cannabis-based treatments, the company sees a notable demand gap. Akanda's subsidiary, Canmart, is focusing on expanding patient access and education while forming partnerships to introduce innovative products to the market. The overall trend indicates a robust and burgeoning market for cannabis in the UK following its legalization for medicinal use.
Read more →-AKAN
Feb 2, 2024Akanda Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules London
Akanda Corp. has successfully closed a registered direct offering, selling 280,851 common shares and pre-funded warrants for a total gross proceeds of approximately $708,000. The offering was executed under Nasdaq rules, with plans for the proceeds to be allocated towards capital expenditures, working capital, and debt refinancing. The company aims to enhance its operational capabilities and expand its portfolio through this investment. The offering was made under an effective shelf registration statement previously filed with the SEC.
Read more →-AKAN
Feb 2, 2024Filed by newsfilecorp.com Akanda Corp. Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules London
Akanda Corp. has announced a registered direct offering with accredited investors to sell 280,851 common shares at $0.406 per share, along with pre-funded warrants for an additional 1,462,991 shares. The gross proceeds from this offering are estimated to reach around $708,000 before fees and expenses. Funds from the offering are intended for general working capital and corporate expenditures. The offering is made pursuant to an effective shelf registration statement declared by the SEC.
Read more →-AKAN
Feb 1, 2024Akanda Corp. Entered into Non-Binding Letter of Intent for Sale of RPK London
Akanda Corp. has announced the extension of a Non-Binding Letter of Intent with Somai Pharmaceuticals for the sale of its subsidiary RPK. The amended agreement includes a reduced purchase price of USD $2 million, down from USD $2.7 million, with conditions placed on the closing of the transaction. The closing is subject to due diligence and other customary requirements, emphasizing uncertainty surrounding the completion of the sale.
Read more →-AKAN
Jan 4, 2024Akanda Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule LONDON
Akanda Corp. has been granted an additional 180 days by Nasdaq to comply with the minimum bid price rule, extending their deadline to July 1, 2024. This extension is contingent on the company successfully maintaining a stock price of $1.00 or higher for at least 10 consecutive business days. In preparation, Akanda is considering a reverse stock split if necessary. The notification currently does not impact the trading status of Akanda's shares on Nasdaq.
Read more →-AKAN
Dec 29, 2023Akanda Corp. Unaudited Condensed Interim Consolidated Statements of Financial Position (Expressed in United States Dollars) As at June 30, December 31, Note 2023 2022 ASSETS Current Cash $ 443,338 $ 228,794 Cash held in
Akanda Corp. reported its interim financial results for the six months ending June 30, 2023, showing a significant increase in sales and cash reserves. However, the company faced a substantial net loss of $5,877,882, which is a rise from the prior year's loss of $2,593,744. Additionally, its accumulated deficit expanded, now totaling $(26,965,844). High operating expenses continue to be a challenge despite revenue growth.
Read more →-AKAN
Dec 11, 2023Akanda Corporation Announces CFO Appointment LONDON
Akanda Corporation has appointed Charn Deol as the new Chief Financial Officer, effective immediately. Deol joins the company with over 35 years of experience in financial markets, including roles in various public companies. This leadership change aims to guide Akanda through its business transition as it seeks to enter early-stage European and global cannabis markets. Akanda's operations include partnerships with recognized industry players, reinforcing its market position.
Read more →-AKAN
Sep 22, 2023Execution Copy AMENDED AND RESTATED OPTION TO PURCHASE THIS AMENDED AND RESTATED OPTION TO PURCHASE (THIS " AGREEMENT ") is made as of
An amended and restated option to purchase agreement has been made as of September 22, 2023, involving B.C. LTD. and CORP. The owner grants an exclusive option to the optionee to purchase specified lands for USD 4,300,000. The agreement includes details about the purchase price, option fee, and obligations regarding property access and inspections. It also outlines the parties' responsibilities in achieving milestones related to the transaction.
Read more →-AKAN
Sep 20, 2023AKANDA CORP. ANNOUNCES SIGNING OF OPTION TO DEVELOP CANADIAN THC AND CBD FARMING FACILITY FRANKFURT, Germany & LONDON --(BUSINESS WIRE)-- International medical cannabis company Akanda Corp. (" Akanda" or the "Company") (
Akanda Corp. has announced an agreement to secure an option for developing a THC and CBD farming facility in Canada. The company will make a non-refundable payment of $1.8 million, with additional payments tied to milestone achievements over a two-year period. This strategic move aims to expand Akanda's operations in the burgeoning cannabis market, leveraging partnerships with established companies to enhance its portfolio.
Read more →-AKAN
Jul 6, 2023Akanda Corp. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency LONDON
Akanda Corp. has received a notification from Nasdaq regarding non-compliance with its minimum bid price requirement after its common shares traded below $1.00 for 30 consecutive days. The company has until January 1, 2024, to regain compliance or risk delisting. Despite this notification, Akanda's business operations remain unaffected, and the company is considering options such as a reverse stock split to meet the requirements. The company aims to monitor its share price closely in the coming months.
Read more →-AKAN
May 30, 2023AKANDA CORP. ANNOUNCES TERMINATION OF LOAN AGREEMENT FRANKFURT, Germany & LONDON --(BUSINESS WIRE)-- International medical cannabis company Akanda Corp. ("Akanda" or the "Company") (NASDAQ: AKAN, WKN: A3DG83) announces t
Akanda Corp. has announced the mutual termination of a loan agreement with Veridia Canada Ltd., which was originally established on April 18, 2023. The company has returned all funds provided under this agreement and now has no further obligations to the lender. This development could raise concerns regarding Akanda’s financial stability and strategic planning moving forward.
Read more →-AKAN
Apr 28, 2023Akanda Corp. Announces Loan Agreement FRANKFURT and LONDON
Akanda Corp. has announced a loan agreement with Veridia Canada Ltd., amounting to $500,000, to support its financial commitments. The loan is secured by RPK's inventory and accounts receivable and does not bear interest unless not repaid within 90 days. The company plans to use these funds to implement its strategic plans while exploring longer-term financing options. Akanda maintains a robust portfolio in the medical cannabis sector, including operations in Europe and Africa.
Read more →-AKAN
Mar 29, 2023Akanda Corporation Has Regained Compliance with NASDAQ's Minimum Bid Price Requirement LONDON
Akanda Corporation has announced that it has regained compliance with the NASDAQ minimum bid price requirement. Following a notification from NASDAQ, the company confirmed its shares closed at a bid price of $1.00 or greater for the required 12 consecutive business days. This update closes the compliance matter that was initiated due to previous non-compliance. Akanda operates as an international medical cannabis platform, providing access to high-quality cannabis products.
Read more →-AKAN
Mar 8, 2023Akanda Corporation Announces 1-for-10 Reverse Stock Split LONDON
Akanda Corporation has announced a 1-for-10 reverse stock split effective March 9, 2023. This action will reduce the number of its issued ordinary shares while maintaining shareholders' percentage interests. The decision was approved by the company's board and shareholders. The reverse split aims to potentially enhance the stock's market price, although it may also signal previous performance issues.
Read more →-AKAN
Feb 17, 2023Canmart Ends CEO Service Agreement; Akanda Approves Appointment of Director LONDON, February 16 th , 2023 - International medical cannabis platform company Akanda Corp. ("Akanda" or the "Company") (NASDAQ: AKAN) today an
Akanda Corp. announced the termination of Tejinder Virk's Service Agreement with immediate effect as of February 13, 2023, due to alleged breaches of contract. Katie Field has taken over his responsibilities temporarily while the Board seeks a new Chief Executive Officer. Additionally, David Jenkins was approved as a new Director to replace Yuying Liang, who resigned for personal reasons. The company continues to expand its international medical cannabis operations with various strategic partnerships.
Read more →-AKAN
Feb 7, 2023Akanda Corp.'s Chief Executive Officer Submits Resignation LONDON
Akanda Corp.'s CEO, Tejinder Virk, has resigned due to disagreements related to contractual obligations under a Service Agreement. Virk claims he was owed money and benefits, which the company disputes. Although the company has not yet accepted his resignation pending a legal review, it is actively searching for a successor to fill the CEO position. In the interim, Executive Director Katie Field has taken over his responsibilities.
Read more →-AKAN
Jan 4, 2023x200B; Akanda Corp. Unaudited Condensed Consolidated Statements of Financial Position (Expressed in US Dollars) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
Akanda Corp. reported its unaudited condensed consolidated financial statements for the six months ended June 30, 2022. The company experienced a substantial operating loss of over $10.9 million, due in part to losses from its discontinued operations. Additionally, Akanda lost control of its subsidiary Bophelo Bio Science and Wellness as a result of a liquidation order from the Lesotho court. The report also notes a substantial accumulated deficit and various expenses leading to net losses during the period.
Read more →-AKAN
Dec 23, 2022Akanda Corp.'s Chief Executive Officer On Paid Leave of Absence
Akanda Corp.'s Chief Executive Officer On Paid Leave of Absence LONDON, December 21, 2022 - International medical cannabis platform company Akanda Corp. ("Akanda" or the "Company") (NASDAQ: AKAN) today announced that Chief Executive Officer Tej Virk has been on a paid leave of
Read more →-AKAN
Nov 14, 2022EUROPE'S PREMIUM CANNABIS CULTIVATOR NOVEMBER 2022 DISCLAIMER FORWARD - LOOKING STATEMENTS Various statements contained in this presentation, including those that express a belief, expectation or intention, as well a s t
EUROPE'S PREMIUM CANNABIS CULTIVATOR NOVEMBER 2022 DISCLAIMER FORWARD - LOOKING STATEMENTS Various statements contained in this presentation, including those that express a belief, expectation or intention, as well a s t hose that are not statements of historical fact, are forwa
Read more →-AKAN
Nov 1, 2022AKANDA CORP. NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING TO BE HELD ON NOVEMBER 22, 2022
NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING TO BE HELD ON NOVEMBER 22, 2022 MANAGEMENT INFORMATION CIRCULAR NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS (the "Notice") NOTICE IS HEREBY GIVEN that an annual general and special meeting (the "Meeting") of the
Read more →-AKAN
Sep 28, 2022Akanda Plans First Shipment of Medical Cannabis to Germany and Anticipates Leading Market Share Position Akanda prepares first export shipment to Germany of high THC indoor cultivated premium cannabis from its Portugal-b
Plans First Shipment of Medical Cannabis to Germany and Anticipates Leading Market Share Position LONDON - International medical cannabis platform company Akanda Corp. ("Akanda" or the "Company") (NASDAQ: AKAN) expects to take a leading position in the fast-growing German medi
Read more →-AKAN
Sep 27, 2022Akanda Corp. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency LONDON, October 3 - International medical cannabis platform company Akanda Corp. ( Akanda or the "Company") (NASDAQ: AKAN) today announced
Akanda Corp. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency October 3 - International medical cannabis platform company Akanda Corp. ("Akanda" or the "Company") (NASDAQ: AKAN) today announced that the Company has received a written notification (the "Notif
Read more →-AKAN
Sep 13, 2022Akanda Partners with Cookies to Bring the Iconic Cannabis Brand and High THC Strains to European Consumers for the First Time Exclusive licensing agreement enables Akanda to cultivate, manufacture and sell Cookies brande
Partners with Cookies to Bring the Iconic Cannabis Brand and High THC Strains to European Consumers for the First Time licensing agreement enables Akanda to cultivate, manufacture and sell Cookies branded products in Portugal, including operating Cookies branded pharmacy outlet
Read more →-AKAN
Sep 8, 2022Founder of Aurora Cannabis Terry Booth, Joins Akanda as Chair of Advisory Board Proven Global Cannabis Executive Joins to Help Guide Akanda's European Strategy London
of Aurora Cannabis Terry Booth, Joins Akanda as Chair of Advisory Board Proven Global Cannabis Executive Joins to Help Guide Akanda's European Strategy London, September 8, 2022: International cannabis company Akanda Corp. ("Akanda" or the "Company") (NASDAQ: AKAN) today anno
Read more →-AKAN
Aug 24, 2022Akanda Bolsters Leadership Team to Scale Medical Cannabis Platform Across Europe Tom Flow Named Chief Operating Officer and Steven George Named Commercial Director The Company announced that it has appointed Steven Georg
Leadership Team to Scale Medical Cannabis Platform Across Europe Chief Operating Officer and Steven George Named Commercial Director Company announced that it has appointed Steven George to the role of Commercial Director of Akanda Company announced that it has appointed Tom F
Read more →-AKAN
Aug 9, 2022Cansativa Group and Akanda Corp. to Bring New Medical Cannabis Flowers to Germany Frankfurt am Main and London
Group and Akanda Corp. to Bring New Medical Cannabis Flowers to Germany Main and London, August 9, 2022 - Akanda Corp. ("Akanda") (NASDAQ: AKAN) and Cansativa GmbH ("Cansativa Group") today jointly announced a new cooperation that will soon allow German pharmacies to provide pa
Read more →-AKAN
Jul 26, 2022Akanda to Contest Unauthorized Liquidation of its Lesotho-Based Subsidiary, Bophelo Bio Science & Wellness (Pty) Ltd. Executive Chairman Louisa Mojela Terminated for Cause London
Akanda to Contest Unauthorized Liquidation of its Lesotho-Based Subsidiary, Bophelo Bio Science & Wellness (Pty) Ltd. Executive Chairman Louisa Mojela Terminated London, July 26, 2022 - Akanda Corp. ("Akanda" or the "Company") (NASDAQ: AKAN), an international medical cannabi
Read more →-AKAN
Jul 12, 2022Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF , a Potential Multimillion Dollar Prescription Drug Provides Tetra with stable supply of high-quality ingredients and regulat
Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF , a Potential Multimillion Dollar Prescription Drug with stable supply of high-quality ingredients and regulatory-approved services to satisfy clinical trials and prescription products Akanda into can
Read more →-AKAN
Jun 23, 2022AKANDA CORP. NOTICE OF RESOLUTION IN LIEU OF MEETING NOTICE IS HEREBY GIVEN that, on
NOTICE OF RESOLUTION IN LIEU OF MEETING GIVEN that, on June 23, 2022, pursuant to Section 104(1)(c) of the Business Corporations Act (Ontario), the holders of at least a majority of the common shares of Akanda Corp. (the "Corporation") passed an ordinary resolution (the "Writt
Read more →-AKAN
Jun 23, 2022Akanda Announces Changes to Board of Directors and Postponement of Annual General Meeting Toronto
Akanda Announces Changes to Board of Directors and Postponement of Annual General Meeting June 23, 2022 - Akanda Corp. ("Akanda" or the "Company") today announced certain changes to its board of directors (the "Board") and the postponement of its annual general meeting of shar
Read more →-AKAN
Jun 6, 2022AKANDA CORP. NOTICE OF ANNUAL GENERAL MEETING TO BE HELD ON JUNE 24, 2022
NOTICE OF ANNUAL GENERAL MEETING TO BE HELD ON JUNE 24, 2022 MANAGEMENT INFORMATION CIRCULAR NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS GIVEN that an annual general meeting (the "Meeting") of the holders (the "Shareholders") of common shares (the "Common Shares") of Ak
Read more →-AKAN
May 2, 2022Akanda Completes Acquisition of Holigen, Advancing Cannabis Leadership Position in Europe, the Middle East and Africa (EMEA) Adds prized cultivation, manufacturing and distribution assets and an award-winning genetics li
Completes Acquisition of Holigen, Advancing Cannabis Leadership Position in Europe, the Middle East and Africa (EMEA) prized cultivation, manufacturing and distribution assets and an award-winning genetics library, accelerating Akanda's seed-to-patient May 2, 2022: Internationa
Read more →-AKAN
Apr 20, 2022AKANDA TO ACQUIRE PORTUGAL-BASED HOLIGEN, SECURING A CANNABIS SECTOR LEADERSHIP POSITION IN EUROPE, THE MIDDLE EAST AND AFRICA (EMEA) WITH EU GMP MARKET ACCESS Transformational deal will add prized cultivation, manufactu
PORTUGAL-BASED HOLIGEN, SECURING A CANNABIS SECTOR LEADERSHIP POSITION IN EUROPE, THE MIDDLE EAST AND AFRICA (EMEA) WITH EU GMP MARKET Transformational deal will add prized cultivation, manufacturing and distribution assets to accelerate Akanda's seed-to-patient model and satis
Read more →-AKAN
Mar 17, 2022Akanda Corp. Closes Initial Public Offering London
Akanda Corp. Closes Initial Public Offering March 17, 2022 - Akanda Corp. ("Akanda" or the "Company"), an international medical cannabis company, today announced the completion of its initial public offering of 4,000,000 common shares at a price of $4.00 per share to the publi
Read more →-AKAN
Mar 15, 2022Akanda Corp. Closes Its First Day of Trading on The NASDAQ Capital Market London
Its First Day of Trading on The NASDAQ Capital Market London, March 15, 2022 - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today commenced the trading of its common shares on The Nasdaq Capital Market under the ticker sym
Read more →-AKAN
Mar 15, 2022Akanda Corp. Common Shares Set to Commence Trading Today on Nasdaq Under Ticker Symbol "AKAN" London
Shares Set to Commence Trading Today on Nasdaq Under Ticker Symbol "AKAN" London, March 15, 2022 - Akanda Corp (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced the Company's common shares are scheduled to commence trading t
Read more →-AKAN
Mar 14, 2022Akanda Corp. Announces Pricing of Initial Public Offering London
Akanda Corp. Announces Pricing of Initial Public London, March 14, 2022 - Akanda Corp. ("Akanda" or the "Company"), an international medical cannabis company, today announced the pricing of its initial public offering of 4,000,000 common shares at a price of $4.00 per share to
Read more →Competitive Position
How AKAN ranks across every disease it competes inCompetitive Position is a premium feature
See how AKAN ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial